Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New discoveries about nitric oxide can provide drugs for schizophrenia

21.11.2007
Problems with memory and social function in patients with schizophrenia may result from an imbalance in the brain's nitric oxide system. A dissertation from the Sahlgrenska Academy shows that rats with characteristics of schizophrenia regain normal brain function if they receive drugs that reduce the production of nitric oxide in the brain.

Schizophrenia is a serious and common disease that can cause hallucinations, delusions and apathy. Problems with memory, social cognition and other intellectual abilities are also common.

"Schizophrenic patients can be treated with anti-psychotic drugs, but the treatment does not help cognitive disturbances or impaired social function to any appreciable degree. We believe that this is due to an imbalance in the brain's nitric oxide system, and if this is the case, we may be able to develop a completely new type of treatment," says pharmacologist Caroline Wass.

In these studies, rate and mice were given a drug called phencyclidine. This substance causes a schizophrenia-like state in humans.

... more about:
»Oxide »Wass »function »nitric »schizophrenia

"Rats and mice don't become schizophrenic, but the drug has a similar effect on thought processes in rodents to the effect it has in humans," says Caroline Wass.

The animals' learning capacity, memory and social interaction were measured using several different behaviour models. When the animals were treated with a substance that blocks brain nitric oxide production, they became resistant to the schizophrenia-like effects of phencyclidine.

The research team will shortly initiate a patient study in order to find out whether blocking brain nitric oxide production can alleviate cognitive disturbances in patients with schizophrenia.

"In the future it is possible that drugs that affect the regulation of nitric oxide in the brain can be used to supplement currently existing anti-psychotic agents. The hope is that nitric oxide inhibiting drugs will alleviate the cognitive disturbances that also lie behind the impairments of social function, significantly improving the chances of a good life for schizophrenic patients," says Caroline Wass.

SCHIZOPHRENIA FACTS
Schizophrenia is a psychiatric illness that affects 1% of the population. There is no cure, but the psychotic symptoms can be treated with psychotropic drugs. The illness often first appears in the twenties. It is usually chronic, and most sufferers never return to work or to full-time education.
Dissertation for research doctorate in medicine from the Sahlgrenska Academy, Institute of Neuroscience and Physiology
Title of dissertation: Cognition and social behaviour in schizophrenia:
An animal model investigating the potential role of nitric oxide
The dissertation will be publically defended on Wednesday 14th December at 09.00, Room 2118, Arvid Wallgrens Backe, hus 2, Göteborg.

For further information contact: Caroline Wass, Pharmacologist, telephone: +46 (0)31 786 3420, +46 (0)70 498 4958, email: caroline.wass@pharm.gu.se Supervisors: Associate professor Lennart Svensson, telephone: +46 (0)31 786 3402, email: lennart.svensson@pharm.gu.se Professor Jörgen Engel, telephone: +46 (0)31 786 3416, email: jorgen.engel@pharm.gu.se Professor Trevor Archer, telephone: +46 (0)31 786 4694, email: trevor.archer@psy.gu.se Dr. Daniel Klamer PhD, telephone: +46 (0)31 786 3403, email: daniel.klamer@pharm.gu.se

Pressofficer: Elin Lindström Claessen; elin.lindstrom@sahlgrenska.gu.se;
+46-70 829 43 03

Elin Lindström Claessen | idw
Further information:
http://www.vr.se

Further reports about: Oxide Wass function nitric schizophrenia

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>